Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 159
Study Shows Arthritis Drug Xeljanz Poses Risk of Heart Problems, Cancer, FDA Warns
Mass. Federal Lawsuit Targeting Allergan’s Soft Tissue Implant Survives Dismissal Motion
Manufacturing Defect, Warranty Claims Proceed to Trial in Intragastric Balloon Action
11th Cir. Says Failure to Meet Ascertainability Requirement Does Not Doom Class Certification